US FDA moves to curtail primate testing in drug trials

The U.S. Food and Drug Administration on Tuesday issued new draft guidance on reducing the use of lab monkeys in preclinical ...

FDA’s top drug officer set to exit, weeks into new role

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was tapped to lead the FDA’s drug division, according to four people familiar with ...

Top FDA Drug Regulator Pazdur to Retire Weeks Into New Role

Richard Pazdur, the US Food and Drug Administration’s lead drug regulator, plans to retire from the agency only weeks after ...

Marty Makary touts FDA efforts to crack down on ‘out of control’ pharmaceutical ads and end animal testing in ‘Pod Force One’ interview

It’s getting out of control. It’s distorting the doctor-patient relationship, these endless pharmaceutical ads,” Makary told ...

More FDA drama: Top drug regulator calls it quits after 3 weeks

The top drug regulator at the Food and Drug Administration, Richard Pazdur, has decided to retire from the agency just three ...

FDA Issues New Safety Warning After Finding 9 More Lead-Leaching Cookware Brands

The FDA expanded its recall of imported aluminum and brass cookware after tests showed certain products can leach harmful ...

FDA chief promises ‘powerful’ new treatments for cancer, neuro disorders under Trump admin in ‘Pod Force One’ interview

Powerful” new treatments for various types of cancer and neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, and ...
STATOpinion

The Trump administration is turning drug review into make-a-deal

FDA decision-making may be reduced to a sequence of ‘make-a-deals’ with Trump, his FDA, or even political allies,” experts ...

F.D.A. Seeks More Oversight of Vaccine Trials and Approvals

The agency’s top vaccine regulator proposed broad changes, claiming that a new review linked 10 children’s deaths to the ...
MIT Technology Review

Here’s what food and drug regulation might look like under the Trump administration

Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and "unleash AI." This story is part of MIT Technology Review’s "America Undone” ...